PubMed:23528904 JSON TXT 10 Projects

Annnotations TAB TSV DIC JSON TextAE

Id	Subject	Object	Predicate	Lexical cue
TextSentencer_T1	0-76	Sentence	denotes	Management of stage 4S composite neuroblastoma with a MYCN-amplified nodule.
T1	0-76	Sentence	denotes	Management of stage 4S composite neuroblastoma with a MYCN-amplified nodule.
TextSentencer_T2	77-157	Sentence	denotes	MYCN amplification in neuroblastoma is usually associated with a poor prognosis.
T2	77-157	Sentence	denotes	MYCN amplification in neuroblastoma is usually associated with a poor prognosis.
TextSentencer_T3	158-297	Sentence	denotes	Very few cases of heterogenous MYCN amplification have been previously reported, and the clinical significance of heterogeneity is unclear.
T3	158-297	Sentence	denotes	Very few cases of heterogenous MYCN amplification have been previously reported, and the clinical significance of heterogeneity is unclear.
TextSentencer_T4	298-433	Sentence	denotes	We report a neonate with an adrenal stage 4S neuroblastoma with a small focus of MYCN-amplified cells within a nonamplified background.
T4	298-433	Sentence	denotes	We report a neonate with an adrenal stage 4S neuroblastoma with a small focus of MYCN-amplified cells within a nonamplified background.
TextSentencer_T5	434-556	Sentence	denotes	After adrenalectomy, the patient has been observed without use of chemotherapy and has no evidence of disease progression.
T5	434-556	Sentence	denotes	After adrenalectomy, the patient has been observed without use of chemotherapy and has no evidence of disease progression.